Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumor necrosis factor-related apoptosis-inducng ligand-induced apoptosis in human colon cancer cells

Cancer Research

Volumn 62, Issue 17, 2002, Pages 4903-4908

  Tang, Ximing ^a   Sun, Yun Jie ^a   Half, Elizabeth ^a   Kuo, M Tien ^a   Sinicrope, Frank ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; COMPLEMENTARY DNA; CYCLOOXYGENASE 2; DEATH RECEPTOR 4; DEATH RECEPTOR 5; MEMBRANE RECEPTOR; MESSENGER RNA; PROTEIN BCL 2; SULINDAC SULFIDE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER RESISTANCE; CELL VIABILITY; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME ACTIVATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RECEPTOR UPREGULATION; TRANSCRIPTION REGULATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASPASES; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; DRUG RESISTANCE, NEOPLASM; ENZYME ACTIVATION; HUMANS; ISOENZYMES; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036735391     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. The role of cyclooxygenases in inflammation, cancer, and development
2. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway
3. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
4. Suppression of intestinal polyposis in Apc Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
5. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
6. Cyclooxygenase-2 overexpression confers resistance to anti-neoplastic drug-induced apoptosis and up-regulates the anti-apoptotic Bcl-2 protein
7. COX-2 inhibits Fas-mediated apoptosis in cholangiocarcinoma cells
8. Mitochondria and apoptosis
9. Apoptosis control by death and decoy receptors
10. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors
11. TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD 4 T cell killing of target cells
12. Killer/DR5 is a DNA damage-inducible p53-regulated death receptor gene
13. TRAIL receptor-2 signals apoptosis through FADD and caspase-8
14. L-overexpressing chemotherapy-resistant tumor cells
15. Selectivity of TRAIL-mediated apoptosis of cancer cells and synergy with drugs: The trail to non-toxic cancer therapeutics
16. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked
17. Role of BAX in the apoptotic response to anticancer agents
18. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: Growth inhibition by nonsteroidal anti-inflammatory drugs
19. Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: Effects on cell cycle and apoptosis
20. The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis
21. Rectal epithelial apoptosis in familial adenomatous polyposis patients treated with sulindac
22. Chemoprevention of colorectal cancer
23. Induction of multidrug resistance proteins MRP1 and MRP3 and γ-glutamylcysteine synthetase gene expression by nonsteroidal anti-inflammatory drugs in human colon cancer cells
24. Sulindac sulfide-induced apoptosis involves death receptor 5 and the caspase 8-dependent pathway in human colon and prostate cancer cells
25. Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo
26. Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity
27. TRAIL (APO-2L) induces apoptosis in human prostate cancer cells that is inhibitable by Bcl-2
28. Cytochrome c and dATP-dependent formation of Apaf-2/Caspase-9 complex initiates an apoptotic protease cascade
29. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-RI/Fas death
30. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells
31. Failure of Bcl-2 to block cytochrome c redistribution during TRAIL-induced apoptosis
32. Overexpression of BCL2 blocks TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human lung cancer cells
33. TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells
34. Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: Its suppression by ectopic expression of Bcl-2 and Bcl-xl